Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 14, 2024

BUY
$293.94 - $358.71 $1.73 Million - $2.12 Million
5,900 Added 393.33%
7,400 $2.65 Million
Q4 2023

Feb 14, 2024

SELL
$253.85 - $299.46 $279,235 - $329,406
-1,100 Reduced 42.31%
1,500 $449,000
Q3 2023

Nov 14, 2023

BUY
$266.54 - $302.43 $399,810 - $453,645
1,500 Added 136.36%
2,600 $710,000
Q4 2022

Feb 14, 2023

SELL
$205.51 - $253.93 $61,653 - $76,179
-300 Reduced 21.43%
1,100 $268,000
Q3 2022

Nov 14, 2022

BUY
$189.27 - $231.83 $264,978 - $324,562
1,400 New
1,400 $284,000
Q1 2022

May 13, 2022

BUY
$245.33 - $277.77 $981,320 - $1.11 Million
4,000 Added 500.0%
4,800 $1.28 Million
Q4 2021

May 03, 2022

BUY
$236.63 - $276.44 $189,304 - $221,152
800 New
800 $214,000

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $129B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.